CARTER BRUCE L A
Insider CIK 1225503 · ENTA Director · XNCR Director · RGLS Director · MRTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2026-03-11 | 2026-03-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2025-03-13 | 2025-03-14 | 15,700 | — | $0 | 15,700 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2024-03-06 | 2024-03-08 | 15,700 | — | $0 | 15,700 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 11,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 10,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 7,520 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 6,021 | — | $0 | 11,252 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 4,444 | — | $0 | 6,808 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 6,808 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-12-29 | 2024-01-03 | 6,808 | $58.75 | $400.0K | 17,273 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2023-03-02 | 2023-03-06 | 10,800 | — | $0 | 10,800 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2023-01-20 | 2023-01-24 | 7,520 | — | $0 | 7,520 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-01-20 | 2023-01-24 | 4,444 | — | $0 | 10,465 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2022-08-12 | 2022-08-16 | 10,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2022-08-12 | 2022-08-16 | 10,000 | $27.00 | $270.0K | 16,021 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2022-08-12 | 2022-08-16 | 5,107 | $85.04 | $434.3K | 10,914 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2022-08-12 | 2022-08-16 | 4,893 | $85.96 | $420.6K | 6,021 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2022-03-21 | 2022-03-22 | 6,000 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2022-03-21 | 2022-03-22 | 807 | $69.52 | $56.1K | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2022-03-21 | 2022-03-22 | 2,210 | $68.66 | $151.7K | 807 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2022-03-21 | 2022-03-22 | 6,000 | $25.58 | $153.5K | 6,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2022-03-21 | 2022-03-22 | 2,676 | $66.70 | $178.5K | 3,324 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2022-03-21 | 2022-03-22 | 307 | $67.23 | $20.6K | 3,017 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2022-03-03 | 2022-03-07 | 7,500 | — | $0 | 7,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2022-01-14 | 2022-01-18 | 3,688 | — | $0 | 3,688 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2022-01-14 | 2022-01-18 | 2,546 | — | $0 | 6,021 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-04-05 | 2021-04-06 | 2,250 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-04-05 | 2021-04-06 | 2,250 | $6.78 | $15.3K | 5,725 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-04-05 | 2021-04-06 | 1,968 | $176.70 | $347.7K | 3,757 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-04-05 | 2021-04-06 | 282 | $180.00 | $50.8K | 3,475 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2021-03-02 | 2021-03-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-02-02 | 2021-02-03 | 2,250 | — | $0 | 2,250 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-02-02 | 2021-02-03 | 300 | $192.32 | $57.7K | 3,693 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-02-02 | 2021-02-03 | 1,732 | $190.50 | $329.9K | 3,993 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-02-02 | 2021-02-03 | 2,250 | $6.78 | $15.3K | 5,725 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-02-02 | 2021-02-03 | 218 | $194.38 | $42.4K | 3,475 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 2,155 | — | $0 | 2,155 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2021-01-15 | 2021-01-20 | 1,475 | — | $0 | 3,475 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-12-14 | 2020-12-16 | 2,250 | — | $0 | 4,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 49 | $240.93 | $11.8K | 4,201 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-12-14 | 2020-12-16 | 2,250 | $6.78 | $15.3K | 4,250 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 287 | $244.05 | $70.0K | 3,914 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 589 | $244.97 | $144.3K | 3,325 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 257 | $246.27 | $63.3K | 3,068 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 710 | $247.63 | $175.8K | 2,358 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 357 | $248.28 | $88.6K | 2,001 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-12-14 | 2020-12-16 | 1 | $248.96 | $249 | 2,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-08-11 | 2020-08-13 | 2,250 | — | $0 | 6,750 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-08-11 | 2020-08-13 | 1,300 | $125.78 | $163.5K | 2,950 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-08-11 | 2020-08-13 | 740 | $126.71 | $93.8K | 2,210 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-08-11 | 2020-08-13 | 110 | $127.58 | $14.0K | 2,100 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-08-11 | 2020-08-13 | 2,250 | $6.78 | $15.3K | 4,250 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-08-11 | 2020-08-13 | 100 | $131.16 | $13.1K | 2,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-05-18 | 2020-05-20 | 4,000 | — | $0 | 9,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-05-18 | 2020-05-20 | 4,000 | $106.86 | $427.4K | 2,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-05-18 | 2020-05-20 | 4,000 | $6.78 | $27.1K | 6,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2020-02-26 | 2020-02-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2020-01-03 | 2020-01-07 | 4,000 | — | $0 | 4,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2020-01-03 | 2020-01-07 | 2,000 | — | $0 | 2,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-11-20 | 2019-11-22 | 3,000 | — | $0 | 13,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-11-20 | 2019-11-22 | 3,000 | $94.74 | $284.2K | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-11-20 | 2019-11-22 | 3,000 | $6.78 | $20.3K | 3,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-08-21 | 2019-08-23 | 3,000 | — | $0 | 16,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-08-21 | 2019-08-23 | 3,000 | $6.78 | $20.3K | 3,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-08-21 | 2019-08-23 | 3,000 | $89.24 | $267.7K | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-05-22 | 2019-05-24 | 3,000 | — | $0 | 19,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-05-22 | 2019-05-24 | 3,000 | $75.20 | $225.6K | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-05-22 | 2019-05-24 | 3,000 | $6.78 | $20.3K | 3,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2019-03-11 | 2019-03-12 | 1,546 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2019-03-11 | 2019-03-12 | 1,546 | $23.40 | $36.2K | 1,546 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2019-03-11 | 2019-03-12 | 1,546 | $99.16 | $153.3K | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2019-02-28 | 2019-03-01 | 5,000 | — | $0 | 5,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2019-02-20 | 2019-02-22 | 3,000 | — | $0 | 22,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-02-20 | 2019-02-22 | 1,000 | $73.79 | $73.8K | 1,100 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-02-20 | 2019-02-22 | 1,100 | $74.44 | $81.9K | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2019-02-20 | 2019-02-22 | 3,000 | $6.78 | $20.3K | 3,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-02-20 | 2019-02-22 | 900 | $72.50 | $65.3K | 2,100 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2019-02-12 | 2019-02-13 | 5,000 | — | $0 | 1,546 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2019-02-12 | 2019-02-13 | 5,000 | $90.00 | $450.0K | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2019-02-12 | 2019-02-13 | 5,000 | $23.40 | $117.0K | 5,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2019-02-11 | 2019-02-13 | 2,734 | — | $0 | 6,546 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2019-02-11 | 2019-02-13 | 2,734 | $90.02 | $246.1K | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2019-02-11 | 2019-02-13 | 2,734 | $23.40 | $64.0K | 2,734 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2019-01-17 | 2019-01-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2018-02-28 | 2018-03-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2018-01-18 | 2018-01-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XNCR Xencor Inc | S Sale | 2017-06-14 | 2017-06-16 | 19,698 | $20.61 | $406.0K | 48,880 | SEC↗ |
| XNCR Xencor Inc | S Sale | 2017-06-14 | 2017-06-16 | 302 | $20.63 | $6.2K | 48,578 | SEC↗ |
| XNCR Xencor Inc | S Sale | 2017-06-02 | 2017-06-06 | 2,366 | $22.00 | $52.1K | 68,578 | SEC↗ |
| XNCR Xencor Inc | S Sale | 2017-05-26 | 2017-05-31 | 11,518 | $22.21 | $255.8K | 71,826 | SEC↗ |
| XNCR Xencor Inc | S Sale | 2017-05-26 | 2017-05-31 | 882 | $22.04 | $19.4K | 70,944 | SEC↗ |
| XNCR Xencor Inc | M Exercise deriv | 2017-05-24 | 2017-05-31 | 76,744 | — | $0 | 0 | SEC↗ |
| XNCR Xencor Inc | M Exercise | 2017-05-24 | 2017-05-31 | 76,744 | $0.59 | $45.3K | 83,344 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2017-05-17 | 2017-05-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2017-02-16 | 2017-02-21 | 7,500 | — | $0 | 7,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2016-09-27 | 2016-09-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XNCR Xencor Inc | S Sale | 2016-08-15 | 2016-08-15 | 3,020 | $22.67 | $68.5K | 6,980 | SEC↗ |
| XNCR Xencor Inc | S Sale | 2016-08-15 | 2016-08-15 | 380 | $22.68 | $8.6K | 6,600 | SEC↗ |
| XNCR Xencor Inc | M Exercise deriv | 2016-08-11 | 2016-08-15 | 10,000 | — | $0 | 76,744 | SEC↗ |
| XNCR Xencor Inc | M Exercise | 2016-08-11 | 2016-08-15 | 10,000 | $0.59 | $5.9K | 10,000 | SEC↗ |
| XNCR Xencor Inc | A Award deriv | 2016-06-23 | 2016-07-08 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2016-02-11 | 2016-02-12 | 6,000 | — | $0 | 6,000 | SEC↗ |
| XNCR Xencor Inc | M Exercise deriv | 2015-06-15 | 2015-06-15 | 10,000 | — | $0 | 86,744 | SEC↗ |
| XNCR Xencor Inc | M Exercise | 2015-06-15 | 2015-06-15 | 10,000 | $0.59 | $5.9K | 10,000 | SEC↗ |
| XNCR Xencor Inc | S Sale | 2015-06-15 | 2015-06-15 | 10,000 | $19.21 | $192.1K | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2015-06-10 | 2015-06-26 | 17,500 | — | $0 | 17,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2015-06-10 | 2015-06-26 | 17,500 | — | $0 | 17,500 | SEC↗ |
| XNCR Xencor Inc | A Award deriv | 2015-06-09 | 2015-06-11 | 7,500 | — | $0 | 7,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise deriv | 2015-04-13 | 2015-04-14 | 20,000 | — | $0 | 10,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise | 2015-04-13 | 2015-04-14 | 20,000 | $4.78 | $95.6K | 20,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2015-04-13 | 2015-04-14 | 20,000 | $17.66 | $353.2K | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2015-02-19 | 2015-02-20 | 6,000 | — | $0 | 6,000 | SEC↗ |
| XNCR Xencor Inc | A Award deriv | 2014-06-12 | 2014-06-16 | 7,500 | — | $0 | 7,500 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | A Award deriv | 2014-05-22 | 2014-05-22 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2013-11-22 | 2013-12-06 | 9,280 | — | $0 | 9,280 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2013-06-10 | 2013-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2012-11-07 | 2012-11-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2012-10-31 | 2012-11-08 | 30,000 | — | $0 | 30,000 | SEC↗ |